SCLX Q3 2025 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q3 2025 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$11M-26.8% YoY

Gross Profit

$7M68.5% margin

Operating Income

-$187M-1766.2% margin

Net Income

-$257M-2435.9% margin

EPS (Diluted)

$-22.17

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$276M

Total Liabilities

$456M

Stockholders' Equity

-$177M

Cash & Equivalents

$878,000

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$14M	-26.8%
Gross Profit	$7M	$11M	-32.2%
Operating Income	-$187M	-$20M	-836.4%
Net Income	-$257M	-$4M	-5762.2%